1. Coadministration of ARV (Atripla) and Topiramate disrupts quail cardiac neural crest cell migration
   Thabiso Tshabalala et al, 2021, Birth Defects Research CrossRef
2. Upregulation of MicroRNA-199 (miR-199) Prompts the Apoptosis of K562 Cell in the Model of Mice with Leukemia
   Jijun Hu et al, 2021, Journal of Biomaterials and Tissue Engineering CrossRef
3. Combination of metformin/efavirenz/fluoxetine exhibits profound anticancer activity via a cancer cell-specific ROS amplification
   Beom-Goo Kang et al, 2023, Cancer Biology & Therapy CrossRef
4. HIV‐1, HAART and cancer: A complex relationship
   Anna Shmakova et al, 2020, International Journal of Cancer CrossRef
5. Reverse transcriptase inhibition potentiates target therapy in BRAF-mutant melanomas: effects on cell proliferation, apoptosis, DNA-damage, ROS induction and mitochondrial membrane depolarization
   Luigi Fattore et al, 2020, Cell Communication and Signaling CrossRef
6. An Epigenetic LINE-1-Based Mechanism in Cancer
   Patrizia Lavia et al, 2022, International Journal of Molecular Sciences CrossRef
7. Comparison of Efavirenz and Doravirine Developmental Toxicity in an Embryo Animal Model
   Daniela Zizioli et al, 2023, International Journal of Molecular Sciences CrossRef
8. Reverse transcriptase inhibitors promote the remodelling of nuclear architecture and induce autophagy in prostate cancer cells
   Cristina Bellisai et al, 2020, Cancer Letters CrossRef
9. Efavirenz: History, Development and Future
   Bárbara Costa et al, 2022, Biomolecules CrossRef
10. The Anti-Angiogenic Effects of Anti-Human Immunodeficiency Virus Drugs
    Giovanni Barillari, 2020, Frontiers in Oncology CrossRef
11. Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
    Christina Pfab et al, 2021, Cancers CrossRef